Missense Mutations in SLC26A8, Encoding a Sperm-Specific Activator of CFTR, Are Associated with Human Asthenozoospermia  by Dirami, Thassadite et al.
REPORT
Missense Mutations in SLC26A8, Encoding
a Sperm-Specific Activator of CFTR, Are
Associated with Human Asthenozoospermia
Thassadite Dirami,1,2,3,10 Baptiste Rode,1,2,3,10 Mathilde Jollivet,4 Nathalie Da Silva,1,2,3 Denise Escalier,5
Natacha Gaitch,6 Caroline Norez,4 Pierre Tuffery,7 Jean-Philippe Wolf,1,2,3,8 Fre´de´ric Becq,4
Pierre F. Ray,9 Emmanuel Dulioust,8 Ge´rard Gacon,1,2,3 Thierry Bienvenu,1,2,3,6 and Aminata Toure´1,2,3,*
The cystic fibrosis transmembrane conductance regulator (CFTR) is present in mature sperm and is required for sperm motility and
capacitation. Both these processes are controlled by ions fluxes and are essential for fertilization. We have shown that SLC26A8, a
sperm-specific member of the SLC26 family of anion exchangers, associates with the CFTR channel and strongly stimulates its activity.
This suggests that the two proteins cooperate to regulate the anion fluxes required for correct spermmotility and capacitation. Here, we
report on three heterozygous SLC26A8 missense mutations identified in a cohort of 146 men presenting with asthenozoospermia:
c.260G>A (p.Arg87Gln), c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys). These mutations were not present in 121 controls
matched for ethnicity, and statistical analysis on a control population of 8,600 individuals (from dbSNP and 1000 Genomes) showed
them to be associated with asthenozoospermia with a power > 95%. By cotransfecting Chinese hamster ovary (CHO)-K1 cells with
SLC26A8 variants and CFTR, we showed that the physical interaction between the two proteins was partly conserved but that the
capacity to activate CFTR-dependent anion transport was completely abolished for all mutants. Biochemical studies revealed the pres-
ence of much smaller amounts of protein for all variants, but these amounts were restored to wild-type levels upon treatment with the
proteasome inhibitor MG132. Immunocytochemistry also showed the amounts of SLC26A8 in sperm to be abnormally small in indi-
viduals carrying the mutations. These mutations might therefore impair formation of the SLC26A8-CFTR complex, principally by
affecting SLC26A8 stability, consistent with an impairment of CFTR-dependent sperm-activation events in affected individuals.Infertility is a major public health issue currently affecting
an estimated 7%–12% of couples worldwide. Various
sperm defects, including asthenozoospermia, an impair-
ment of spermmotility, are responsible for male infertility.
Asthenozoospermia is detected in more than 40% of infer-
tile men and is often associated with lower levels of sperm
production and morphological abnormalities (oligoasthe-
noteratozoospermia).1 Despite its high prevalence, very
little is known about the genetic abnormalities potentially
underlying human asthenozoospermia.
Ion fluxes play an essential role in the control of sperm
motility and capacitation, a maturation event that occurs
in the female genital tract and is required for fertilization.
In particular, calcium, chloride, and bicarbonate influxes
induce an increase in intracellular cyclic AMP concentra-
tion, leading to the activation of protein kinase A and
phosphorylation cascades required for sperm motility
and capacitation.2–6 We previously described SLC26A8,
also known as testis anion transporter 1 (TAT1), as a
male-germ-cell-specific member of the large family of
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sterility as a result of a total lack of sperm motility, an
impairment of sperm capacitation, and severe structural
defects of the flagellum (midpiece disorganization,
hairpin-like bending of the flagellum, and atrophy of the
annulus).8 In agreement with this phenotype, SLC26A8
is located in the equatorial segment of the head and in
the annulus, a ring-shaped structure at the junction
between the midpiece and the principal piece of the flagel-
lum, in mature sperm.8,9
Most members of the SLC26 family transport monova-
lent and/or divalent anions (including sulfate, chloride,
bicarbonate, iodide, and oxalate ions), and individual
members of the SLC26 family might be specifically or
preferentially expressed in particular tissues.10 In humans,
mutations in SLC26A2 (MIM 606718), SLC26A3 (MIM
126650), SLC26A4 (MIM 605646), and SLC26A5 (MIM
604943) have been causally associated with diastrophic
dysplasia (MIM 222600), chloride diarrhea (MIM
214700), Pendred syndrome (MIM 274600), and deafness
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Table 1. Sperm Characteristics of Individuals with Heterozygous Sequence Variants of SLC26A8
Individual
Lower Reference LimitaX1 X2 X3
DNA mutation c.260G>A c.2434G>A c.2860C>T -
Protein alteration p.Arg87Gln p.Glu812Lys p.Arg954Cys -
Age (years) 44 42 31 -
Volume of ejaculate (ml) 1.3 3 2.1 1.5
pH 8.1 7.7 7.9 7.2
Concentration (106 sperm/ml) 252 410 10 15
Progressive motility (PR) (%) 25 30 15 32
Viability (%) 83 79 69 58
Typical forms (%) 16 38 1 4
Morphological defects (%) flagellum (19) flagellum (10) flagellum (39) and head (98) -
The following abbreviation is used: PR, percentage of progressive sperm.
aValues were compared with the lower reference limits established by the World Health Organization.21SLC26 transporters (SLC26A3, SLC26A4, SLC26A5,
SLC26A6, and SLC26A9), present in various epithelia,
form complexes with the cystic fibrosis transmembrane
conductance regulator (CFTR), the chloride and bicarbon-
ate channel that is defective in cystic fibrosis (CF [MIM
219700]), and are able to regulate CFTR transport activ-
ity.12–18 The CFTR channel has been detected in the equa-
torial segment of the head and in the flagellum (midpiece)
of mature sperm and is required for sperm motility
and capacitation.19,20 We recently demonstrated that
SLC26A8 (1) colocalizes with CFTR in mature sperm, (2)
physically interacts with CFTR in vitro and in vivo, and
(3) is a strong activator of CFTR. These observations impli-
cate the SLC26A8-CFTR complex in the in vivo regulation
of the chloride and bicarbonate fluxes required for sperm
motility and capacitation.9
We therefore suspected that mutations of SLC26A8
(MIM 608480) and CFTR (MIM 602421) would impair
sperm motility and capacitation. The aim of this study
was to search for SLC26A8mutations inmenwith astheno-
zoospermia and sperm with a low fertilizing capacity. The
entire study was performed in accordance with ethical
guidelines and was approved by the ethics evaluation
committee of the Institut National de la Sante´ et de la
Recherche Me´dicale (authorization number 01-013) and
by the Comite´ de Protection des Personnes CPP Ile de
France III (authorization number Sc-2748). Informed
consent was obtained from all individuals included in
the study.
We analyzed the 19 exons composing the coding
sequence of SLC26A8 by denaturating high-performance
liquid chromatography and direct sequencing in a cohort
of 146 men being treated for infertility at the Reproductive
Medicine Department of Cochin Hospital. The criteria for
inclusion in the study were asthenozoospermia, defined
as a percentage of progressive sperm (PR) in the ejaculate
of less than 32%, and normal vitality, defined as a percent-The Amage of viable sperm exceeding 58%, and were in line
with the current values established by the World Health
Organization.21 Twenty-seven of the 146 men had severe
asthenozoospermia with a PR < 15%, 67 had a PR between
20% and 25%, and 50 had a PR ¼ 30%.
We identified seven asthenozoospermic individuals car-
rying heterozygous variants of the coding regions of
SLC26A8 (RefSeq accession number NM_052961.3); these
variants were absent from the alleles of 121 controls
matched for ethnicity. Only three of these sequence vari-
ants—c.260G>A (p.Arg87Gln), c.2434G>A (p.Glu812Lys),
and c.2860C>T (p.Arg954Cys)—were deleterious in terms
of their effects on functional cooperation between
SLC26A8 and CFTR (see below); these three variants were
studied in greater detail and are presented in this report.
The main semen parameters for individuals X1, X2,
and X3, carrying the sequence variants c.260G>A
(p.Arg87Gln), c.2434G>A (p.Glu812Lys), and c.2860C>T
(p.Arg954Cys), respectively, are presented in Table 1. Two
of these subjects (individuals X1 and X2) displayed moder-
ate asthenozoospermia, and the third (individual X3) had
more severe asthenozoospermia. Individual X1 had a low
ejaculate volume and a frequency of sperm morphological
abnormalities moderately higher than normal: in partic-
ular, coiled tails (19%) and an abnormally shaped posterior
part of the sperm head (63%) were observed. Furthermore,
the concentration of polymorphonuclear leukocytes ex-
ceeded 1 3 106/ml (LeucoScreen assay). All other semen
parameters were normal in individual X2, although flagel-
lum defects were observed in about 10% of the sperm.
Individual X3 had a low sperm count and a very high
frequency of combined morphological defects, including
abnormal head shape (98%), midpiece abnormalities
(27%), and flagellum defects (38%). No bacteria were de-
tected in cultures of semen from these three individuals.
All three individuals (X1, X2, and X3) were consulting
for primary infertility. Individual X1 is an only childerican Journal of Human Genetics 92, 760–766, May 2, 2013 761
Figure 1. Distribution of SLC26A8 Sequence Variants and Their
Effects on CFTR Stimulation
(A) SLC26A8 is composed of 12 transmembrane helices, including
the transport domain, and a large cytoplasmic region that includes
the regulatory STAS domain (amino acids 543–795). The
p.Arg87Gln (c.260G>A) substitution maps to the junction
between the first transmembrane domain and the extracellular
loop of the protein; the p.Glu812Lys (c.2434G>A) and
p.Arg954Cys (c.2860C>T) substitutions map to the C terminus.
(B) CFTR anion-transport activity was measured by iodide (125I)-
efflux experiments in CHO-K1 cells stably expressing the wild-
type human CFTR (CHO-CFTR) and transiently transfected with
the following expression vectors: pRK5 (empty vector), pCMV-
SLC26A3, pRK5-SLC26A8, pRK5-SLC26A8DSTAS (a truncated
SLC26A8 lacking the STAS domain), pRK5-p.Arg87Gln, pRK5-
p.Glu812Lys, and pRK5-p.Arg954Cys. The experimental
procedures have been described elsewhere.22 Asterisks indicate
that the mean significantly differs from that for pRK5 (t test
p values ¼ 0.0015 [SLC26A3] and 0.0068 [SLC26A8]). Number
signs indicate that the mean significantly differs from that for
wild-type (WT) SLC26A8 (t test p values ¼ 0.0295 [SLC26A8D
STAS], 0.0010 [p.Arg87Gln], 0.0020 [p.Glu812Lys], and 0.0049
[p.Arg954Cys]). The following abbreviation is used: NT, no
transfection.with an unknown father, and his mother has one brother
with no children. Individual X2 has two sisters and four
brothers, all of whom have children. Individual X3 was
conceived after primary infertility of 10 years’ duration;
he is an only child, like his father, and his mother has
one brother and one sister with children.
None of the members of the families of these three indi-
viduals were available for genetic study. For confirmation762 The American Journal of Human Genetics 92, 760–766, May 2, 2of the association between the variants (c.260G>A
[p.Arg87Gln], c.2434G>A [p.Glu812Lys], and c.2860C>T
[p.Arg954Cys]) and human asthenozoospermia, we there-
fore calculated the frequency of these alleles in large
European control populations available from the National
Center for Biotechnology Information website and the
1000 Genomes database (8,600 individuals) and used a
Chi-square test to compare frequencies. For all three iden-
tified variants, the frequency of the mutant allele was
higher (with a power > 95%) in the cohort of asthenozoo-
spermic individuals than in the control groups (Table S1,
available online). The sex and fertility status of the control
individuals were unknown; the presence of infertile men
potentially harboring SLC26A8 mutations in the control
population would increase the power of the analysis
even further.
SLC26 family members have a common structure
comprising a membranous sulfate transport domain with
12 putative transmembrane helices and a cytoplasmic reg-
ulatory domain, known as the STAS (sulfate transporter
and antisigma factor antagonist) domain, at the C termi-
nus.10 The c.260G>A (p.Arg87Gln) mutation affects a
residue located at the junction between the first transmem-
brane domain and the extracellular loop, and both the
c.2434G>A (p.Glu812Lys) and c.2860C>T (p.Arg954Cys)
mutations affect residues in the intracytoplasmic C-termi-
nal region (Figure 1A).
We first assessed the possible pathogenicity of these
sequence variants by in silico analysis with PolyPhen. The
c.260G>A (p.Arg87Gln) variant (individual X1) was scored
as ‘‘possibly damaging’’ (score 0.916), whereas variants
c.2434G>A (p.Glu812Lys) (individual X2) and c.2860C>T
(p.Arg954Cys) (individualX3)were both classified as ‘‘prob-
ably damaging’’ (scores 0.985 and 0.993, respectively).
Next, we assessed the pathogenic effects of these variants
experimentally by establishing eukaryotic expression vec-
tors for each variant, and we then used these vectors for
the transient transfection of Chinese hamster ovary
(CHO-K1) cells; we used this model to determine the abun-
dance and the properties of the variants in terms of their
interaction and cooperation with the CFTR channel.
We performed iodide-efflux experiments by using a
station for robotic flux-cell-based assays to assess the
effects of the variants on CFTR activity.22 We transiently
transfected CHO-K1 cells stably expressing the CFTR chan-
nel with the SLC26A8 wild-type or variant cDNA and
induced CFTR activity with forskolin. As previously
described, SLC26A8, like other SLC26 members
(SLC26A3), strongly stimulated CFTR-associated iodide
efflux.9 The STAS domain mediates the interaction
between several of the SLC26 members and CFTR and is
required for CFTR stimulation.12 We therefore used a trun-
cated SLC26A8 lacking the STAS domain (SLC26A8DSTAS)
as a negative control. The c.260G>A (p.Arg87Gln),
c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys)
variants, like the protein encoded by the SLC26A8DSTAS
construct, failed to stimulate CFTR (Figure 1B).013
Figure 2. Protein Levels and Interaction between SLC26A8 Var-
iants and the CFTR Channel
(A) The interaction between the p.Arg87Gln, p.Glu812Lys,
and p.Arg954Cys variants and the CFTR channel in CHO-K1
cells was assessed by coimmunoprecipitation. Cells were tran-
siently transfected with pRK5-SLC26A8, pRK5-p.Arg87Gln,
pRK5-p.Glu812Lys, or pRK5-p.Arg954Cys and pGFP-CFTR or
pGFP-MRTFA (negative control). A monoclonal CFTR antibody
(M3A7; Millipore) was used for immunoprecipitation (IP), and a
polyclonal SLC26A8 antibody (L2CL4) was used for immunoblot-
ting (IB) of the precipitate, as previously described.9
(B) The amounts of SLC26A8 variants were determined after the
transient transfection of CHO-K1 cells with pRK5-SLC26A8,
pRK5-p.Arg87Gln, pRK5-p.Glu812Lys, or pRK5-p.Arg954Cys.
Both glycosylated and nonglycosylated forms of SLC26A8
were assayed; b-tubulin was used as an internal loading control.
The histogram shows the mean values of five experiments for
the glycosylated form. Asterisks indicate that the mean signifi-
cantly differs from that of the wild-type (p < 0.05) (t test
p values ¼ 0.0002 [p.Arg87Gln], 0.0013 [p.Arg954Cys], and
0.0333 [p.Glu812Lys]). The abundance of CFTR, when cotrans-
fected with SLC26A8 variants, was analyzed in a similar
manner. Bands A, B, and C of CFTR, corresponding to the non-
glycosylated and glycosylated forms of CFTR, were studied. The
histogram represents the mean of four experiments for CFTR
band B. The asterisks indicate that the mean significantly
The AmWe then analyzed the interaction between the
p.Arg87Gln, p.Glu812Lys, and p.Arg954Cys variants and
CFTR in CHO-K1 cells by coimmunoprecipitation experi-
ments. All three variants were found to be associated
with CFTR, but the coimmunoprecipitation yield appeared
to be slightly lower than that for the wild-type (Figure 2A).
We quantified the total amounts of the variants
p.Arg87Gln, p.Glu812Lys, and p.Arg954Cys produced in
the transfected cells. The altered proteins were signifi-
cantly less abundant than the wild-type SLC26A8. The
results of a representative immunoblotting experiment
showing the loading controls are shown in Figure S1.
Several of the extracellular residues of SLC26A8 are
N-glycosylated.7 We found that both nonglycosylated
(not shown) and glycosylated forms of the variants were
less abundant than the wild-type SLC26A8 forms: the
amounts of p.Arg87Gln, p.Glu812Lys, and p.Arg954Cys
were only 54%, 68%, and 66%, respectively, of that of
the wild-type (n ¼ 5; t test p values ¼ 0.0002 [p.Arg87Gln],
0.0333 [p.Glu812Lys], and 0.0013 [p.Arg954Cys])
(Figure 2B).
Cells cotransfected with the c.260G>A (p.Arg87Gln),
c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys)
variants and the wild-type CFTR also resulted in lower
accumulation of CFTR than did control cells; the results
of a representative immunoblotting experiment are shown
in Figure S1. Like SLC26A8, CFTR is glycosylated, and three
bands reflecting different maturation states of the protein
were detected on immunoblots.23 We quantified each
band and found that the amounts of nonglycosylated
forms of CFTR (CFTR bands A and B) were significantly
smaller in cells cotransfected with the c.260G>A
(p.Arg87Gln), c.2434G>A (p.Glu812Lys), or c.2860C>T
(p.Arg954Cys) variant. The intensity of CFTR band B
was 72%, 56%, and 55% of that in control cells when
CFTR was cotransfected with c.260G>A (p.Arg87Gln),
c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys),
respectively (n ¼ 4; t test p values ¼ 0.024, 0.007, and
0.001, respectively; Figure 2B). The abundance of the
mature, fully glycosylated form of CFTR (band C) was
also lower in cells in which it was cotransfected with the
c.2434G>A (p.Glu812Lys) or c.2860C>T (p.Arg954Cys)
variant (not shown).
These results suggest that the c.260G>A (p.Arg87Gln),
c.2434G>A (p.Glu812Lys), and c.2860C>T (p.Arg954Cys)
mutations decrease SLC26A8 stability and potentially
affect the formation of the SLC26A8-CFTR complex.
We tested this hypothesis by quantifying the amounts of
the variant proteins in cells treated with the peptide-
aldehyde proteasome inhibitor MG132. After treatment
with MG132, the abundances of all three altered
proteins were found to be similar to that of the wild-type
SLC26A8 (Figure 3; n ¼ 4: t test p values ¼ 0.014differs from that of the wild-type (p < 0.05) (t test
p values ¼ 0.024 [p.Arg87Gln], 0.001 [p.Arg954Cys], and
0.007 [p.Glu812Lys]).
erican Journal of Human Genetics 92, 760–766, May 2, 2013 763
Figure 3. Levels of SLC26A8 Variants in Cells Treated with the
Proteasome Inhibitor MG132
(A) Results of a representative immunoblot experiment after the
transient transfection of CHO-K1 cells with pRK5-SLC26A8,
pRK5-p.Arg87Gln, pRK5-p.Glu812Lys, or pRK5-p.Arg954Cys and
treatment with 20 mM MG132 for 6 hr. A polyclonal SLC26A8
antibody (L2CL4) and a b-tubulin antibody were used for the
immunoblotting (IB) analysis andas a loadingcontrol, respectively.
(B) Quantification of the amounts of SLC26A8 variants after
MG132 treatment. The histogram represents the mean of four
experiments for the glycosylated form. Asterisks indicate that
the mean significantly differs from that of the wild-type (p <
0.05) (t test p values ¼ 0.022 [p.Arg87Gln], 0.040 [p.Glu812Lys],
and 0.168 [p.Arg954Cys]). Number signs indicate that the mean
significantly differs from that of the control (no MG132 treat-
ment) (p < 0.05) (t test p values ¼ 0.014 [p.Arg87Gln], 0.074
[p.Glu812Lys], and 0.015 [p.Arg954Cys]).[p.Arg87Gln], 0.015 ([p.Arg954Cys], and 0.074
[p.Glu812Lys]). This suggests that the lower abundance
of the variants than of the control protein results from
their instability and proteasomal degradation.
We assessed the impact of the variants in vivo by the im-
munodetection of SLC26A8 in sperm preparations from
individuals X2 (c.2434G>A [p.Glu812Lys]) and X3
(c.2860C>T [p.Arg954Cys]). Too little semen was available
from individual X1 (c.260G>A [p.Arg87Gln]) for this test.
We used an antibody recognizing both amino- and car-
boxy-terminal peptides from human SLC26A8.9 In three
independent experiments, SLC26A8 was detected at the
annulus and in the equatorial segment of spermatozoa
from both individuals and had a signal intensity lower
than that of control sperm (Figure 4A). In addition, sperm
from both individuals displayed morphological defects
that were visible on light microscopy. We conducted a
more detailed characterization of samples from individual
X2 (c.2434G>A [p.Glu812Lys]): mitochondrial staining
revealed an irregular organization of the midpiece,
which was confirmed by electron microscopy (Fig-
ure S2). In most sperm from individual X3 (c.2860C>T764 The American Journal of Human Genetics 92, 760–766, May 2, 2[p.Arg954Cys]), SLC26A8 labeling, when present, was
abnormally diffuse along the midpiece of the flagellum
or absent from the equatorial segment of the head
(Figure 4B). Such mislocalization in vivo would probably
impair the formation of the SLC26A8-CFTR complex and
might therefore potentially contribute to the observed
sperm motility defects.
In conclusion, we report the identification and charac-
terization of heterozygous SLC26A8 missense mutations
that abolish functional interaction with the CFTR channel
and potentially contribute to subfertility inmen by impair-
ing sperm motility and capacitation. We show that the
c.260G>A (p.Arg87Gln), c.2434G>A (p.Glu812Lys), and
c.2860C>T (p.Arg954Cys) mutations impair the formation
and stability of the SLC26A8-CFTR complex through their
effects on SLC26A8 stability and abundance. These find-
ings are consistent with the fact that smaller amounts of
SLC26A8 lead to the presence of too few active SLC26A8-
CFTR complexes in sperm.
Despite our best attempts, we were unable to obtain
DNA from members of the families of these three individ-
uals, and we therefore have no data about the inheritance
of the mutations. All diseases associated with mutations in
SLC26 genes (SLC26A2, SLC26A3, SLC26A4, and SLC26A5)
are autosomal recessive.25 The mutations we identified in
SLC26A8 were found to be heterozygous in all individuals,
suggesting a different mode of inheritance. This difference
might be accounted for by the haploid state of the
germ cells and the unequal sharing of material between
them, despite their connection via intercellular bridges
throughout spermatogenesis. These unique features of
the sperm cell probably strengthen any phenotype result-
ing from monogenic heterozygous alterations and
contribute to the heterogeneity of sperm phenotype in a
given individual. Consistent with this, the individuals
described here presented with mild asthenozoospermia
and heterogeneous sperm phenotypes in terms of sperm
motility and morphology.
Sperm from two of the individuals studied also displayed
morphological abnormalities, such as midpiece disorgani-
zation and an incomplete annulus, similar to the defects
observed in Slc26A8-null sperm in mice.8 This phenotype
is consistent with the dual function of SLC26A8, acting
as a regulator of anion flux and a structural component
of the annulus, the integrity of which is required for cor-
rect flagellum assembly.8,24,26–28
Overall, the clinical study presented here confirms the
importance of functional cooperation between SLC26
family members and the CFTR channel. Consistent with
this concept, a recent genome-wide association study iden-
tified several SLC26A9 (MIM 608481) SNPs affecting the
cystic fibrosis (CF) phenotype. Thus, although CFTR
remains the only gene in which mutations cause CF,
modulation of SLC26 activity might affect the CF pheno-
type in affected individuals.29 Such cooperation between
members of the SLC26 family and CFTR has now been
described in several tissues, including the epithelia.013
Figure 4. Immunodetection of SLC26A8
in Sperm from Individuals X2 and X3
Immunofluorescence studies were per-
formed, as previously described,24 with
methanol- and acetone-fixed sperm prepa-
rations and a polyclonal antibody directed
against SLC26A8 (SE5362). Samples were
examined under a Nikon Eclipse 600
microscope, and digital images were
acquired with NIS-Elements D (Nikon)
software (identical instrument settings
were used in each case) and analyzed
with Image J 1.44cw software (National
Institutes of Health).
(A) Upper panel: merged image with DAPI
(blue), SLC26A8 (red), and phase contrast
(gray). Lower panel: same image in dark
field. The SLC26A8 signal is in white.
(B) Merged image with DAPI (blue),
SLC26A8 (red), and phase contrast (gray).SLC26 transporters appear to be general regulators, most
often activators, of the CFTR channel, and their activity
is essential for CFTR function in vivo. Further study of
SLC26 transporters might improve not only the diagnosis
and treatment of CF but also the quality of sperm for assis-
ted reproduction procedures.Supplemental Data
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